Generic drugmaker Ranbaxy Laboratories reported its first profit of Rs 478 crore for the second quarter ended September 2014, in the last six months. The company made profit on back of exclusive sales of its generic blood pressure pill Diovan in the US. It had registered a loss of Rs 454 crore in the year-ago quarter.